Responsiveness of Inhaled Epoprostenol in Respiratory Failure Due to COVID-19
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Intensive Care Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Responsiveness of Inhaled Epoprostenol in Respiratory Failure due to COVID-19
J Intensive Care Med 2021 Mar 01;36(3)327-333, R Sonti, CW Pike, N CobbFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.